NCT00489307View on ClinicalTrials.gov

Dexamethasone for Symptom Burden in Advanced Cancer Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

February 2, 2006

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2028

Conditions
Solid Tumors
Interventions
DRUG

Dexamethasone

4 mg PO (by mouth) twice daily x 14 days

DRUG

Placebo

Placebo PO twice daily x 14 days

Trial Locations (2)

77030

Lyndon Baines Johnson Hospital, Houston

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

M.D. Anderson Cancer Center

OTHER